GILD
Gilead Sciences Inc
150.90$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.9% | -6.0% | +4.0% | +8.5% | +0.3% | -11.9% | +6.2% | +9.7% | +2.0% | -12.2% | +12.1% | – | |
| – | +33.5% | -25.7% | -0.5% | +1.9% | +0.4% | -2.6% | -2.5% | +4.5% | +3.5% | -11.0% | +9.3% | – | |
| – | -8.4% | +2.2% | +5.4% | +10.4% | +0.3% | -14.4% | +8.8% | +11.1% | +1.6% | -12.5% | +12.9% | – | |
| – | -3.4% | +8.0% | -11.1% | +3.3% | +17.6% | -16.0% | +8.1% | -9.7% | +17.7% | -13.4% | +28.6% | – | |
| – | -42.7% | -16.2% | -9.5% | -22.7% | +124.4% | -49.1% | -0.8% | +5.4% | +23.5% | -15.2% | +247.4% | – | |
| – | +19.2% | +177.1% | -70.8% | +83.8% | -30.4% | -18.3% | +7.5% | -7.5% | +15.3% | -11.6% | +467.4% | – | |
| – | -38.5% | -368.1% | – | -66.4% | +176.1% | -8.8% | +10.6% | +34.5% | -10.2% | -9.9% | -486.1% | – | |
| – | +8.6% | +0.8% | -6.7% | +0.4% | +4.6% | +4.4% | -2.3% | +0.8% | -0.4% | -5.9% | +2.9% | – | |
| – | -28.7% | -371.4% | – | -53.4% | +126.7% | -23.9% | +47.3% | +49.9% | -42.9% | +24.2% | -497.4% | – | |
| – | +62.3% | -232.9% | – | -167.8% | – | -13.2% | +40.1% | +25.9% | -117.8% | – | -56.7% | – | |
| – | -34.4% | -391.8% | – | -22.4% | +42.3% | -26.2% | +49.0% | +55.7% | -28.5% | -7.4% | -619.3% | – | |
| – | -19.8% | -236.6% | – | -36.9% | +65.0% | -16.2% | +29.5% | +35.8% | -34.1% | +16.2% | -385.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.